Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1038-2013Class II

SIEMENS brand COHERENCE RT Therapist versions RTT MR1.5, RTT 2.1/2.1A and RTT 2.2/ 2.2B; Software release for...

Siemens Medical Solutions USA, Inc. / Terminated / root cause: software

Siemens Medical Solutions USA, Inc began a recall of SIEMENS brand COHERENCE RT Therapist versions RTT MR1.5, RTT 2.1/2.1A and RTT 2.2/ 2.2B; Software release for COHERENCE Therapist 2.3 for Primus and Oncor.... FDA classified it as Class II and gives the reason as "Siemen's issued a Customer Information Letter under Update Instruction TH016/12S to alert all its affected customers of the software issues. The software release is a result of the final system testing addressing...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-1038-2013
Classification
Class II
Status
Terminated
Posted
Terminated
Recalling firm
Siemens Medical Solutions USA, Inc.
Product
SIEMENS brand COHERENCE RT Therapist versions RTT MR1.5, RTT 2.1/2.1A and RTT 2.2/ 2.2B; Software release for COHERENCE Therapist 2.3 for Primus and Oncor Linear Accelerators; Model: COHERENCE Impression TH, Part No. 7341410, Current R630; Product Usage: The intended use of the SIEMENS branded ONCOR and PRIMUS family of linear accelerator systems is to deliver X-ray photon and electron radiation for the therapeutic treatment of cancer.
Product code
IYE Accelerator, Linear, Medical
Reason for recall
Siemen's issued a Customer Information Letter under Update Instruction TH016/12S to alert all its affected customers of the software issues. The software release is a result of the final system testing addressing multiple performance defects and several safety issues that were not considered critical (for immediate correction) for the safe use of the device.
Root cause tag
software
FDA root cause
Software design (manufacturing process)
Action
Siemens Medical Solutions sent a Customer Information letter via mail to all affected customers. The letter identified the affected product, problem and provide instructions on the correction. Customers were instructed to include the Customer Information letter in the Owner Manual chapter "Safety Advisory Letters". 9-16-13 UPDATE: - Control Console SW 9.2.18 was released to support the rol-out 10/18/2013; Distribution of update instructions for TH017/13S and TH018/13S - Distribtuion of the Control Console SW 9.2.18 released
Quantity in commerce
621 units (foreign account) in total
Distribution
Worldwide Distribution
Product codes and lots
All units of these models.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1038-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1036-2013Class IITerminatedVoluntary: Firm initiated
Z-1037-2013Class IITerminatedVoluntary: Firm initiated
Z-1038-2013Class IITerminatedVoluntary: Firm initiated
Z-1039-2013Class IITerminatedVoluntary: Firm initiated
Z-1040-2013Class IITerminatedVoluntary: Firm initiated
Z-1041-2013Class IITerminatedVoluntary: Firm initiated
Z-1042-2013Class IITerminatedVoluntary: Firm initiated
Z-1043-2013Class IITerminatedVoluntary: Firm initiated
Z-1044-2013Class IITerminatedVoluntary: Firm initiated